The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
LLM 2021 | Rare blood diseases at LLM 2021
Sangmin Lee, MD, Weill Cornell Medicine, New York, NY, shares key highlights that will be addressed in the rare disease session at the Lymphoma, Leukemia & Myeloma Congress 2021. Dr Lee highlights the latest therapies in development for multiple rare blood diseases including paroxysmal nocturnal hemoglobinuria (PNH), systemic mastocytosis, and large granular lymphocytic (LGL) leukemia. This interview took place at the Lymphoma, Leukemia & Myeloma Congress 2021.
